Bob Uger

Bob Uger

Company: Trillium Therapeutics

Job title: Chief Scientific Officer

Seminars:

Speaker Q&A 12:40 pm

Read more

day: Innate Immune Checkpoints & Activation Pre-Focus Day

Targeting the Innate Immune Checkpoint CD47-SIRPα Axis 11:50 am

The CD47-SIRPa axis suppresses macrophage phagocytosis and has emerged as an important innate immune checkpoint. There are a number of agents targeting this pathway in clinical development, including antibodies, decoy receptors and bispecifics. Emerging clinical data will be discussed.Read more

day: Innate Immune Checkpoints & Activation Pre-Focus Day

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.